or
forgot password
  • cancer clinical trials in state college, PA

  • Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Mount Nittany Medical Center
    State College, Pennsylvania 16803
    Prostate Cancer
    S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
    Geisinger Medical Group - Scenery Park

    Trial Locations
    Geisinger Medical Group - Scenery Park
    Mount Nittany Medical Center
    Melanoma (Skin)
    Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
    Mount Nittany Medical Center
    State College, Pennsylvania 16803
    Breast Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Mount Nittany Medical Center
    State College, Pennsylvania 16803
    Breast Cancer
    Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
    Mount Nittany Medical Center
    State College, Pennsylvania 16803
    Infection, Multiple Myeloma and Plasma Cell Neoplasm
    Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
    Mount Nittany Medical Center
    State College, Pennsylvania 16803
    Breast Cancer
    S0000 Selenium and Vitamin E in Preventing Prostate Cancer
    Geisinger Medical Group - Scenery Park
    State College, Pennsylvania 16801
    Prostate Cancer
    Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
    Geisinger Medical Group - Scenery Park

    Trial Locations
    Geisinger Medical Group - Scenery Park
    Mount Nittany Medical Center
    Lung Cancer
    Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
    Geisinger Medical Group - Scenery Park
    State College, Pennsylvania 16801
    Leukemia
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Geisinger Medical Group - Scenery Park

    Trial Locations
    Geisinger Medical Group - Scenery Park
    Mount Nittany Medical Center
    Esophageal Cancer, Gastric Cancer
    Anastrozole & ZD1839 Compared With Fulvestrant & ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer
    Mount Nittany Medical Center
    State College, Pennsylvania 16803
    Breast Cancer
    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    Geisinger Medical Group
    State College, Pennsylvania 16801
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Imatinib Mesylate or Dasatinib in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
    Mount Nittany Medical Center

    Trial Locations
    Mount Nittany Medical Center
    Geisinger Medical Group
    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia
    Pentostatin, Cyclophosphamide, and Rituximab Followed By Lenalidomide in Treating Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia
    Geisinger Medical Group - Scenery Park

    Trial Locations
    Geisinger Medical Group - Scenery Park
    Mount Nittany Medical Center
    Leukemia
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Mount Nittany Medical Center
    State College, Pennsylvania 16803
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Mount Nittany Medical Center

    Trial Locations
    Mount Nittany Medical Center
    Geisinger Medical Group
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Tipifarnib in Treating Patients With Acute Myeloid Leukemia in Remission
    Mount Nittany Medical Center

    Trial Locations
    Mount Nittany Medical Center
    Geisinger Medical Group
    Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts in Transformation
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Geisinger Medical Group
    State College, Pennsylvania 16801
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
    Geisinger Medical Group
    State College, Pennsylvania 16801
    Recurrent Mantle Cell Lymphoma
    Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Multiple Myeloma
    Geisinger Medical Group - Scenery Park
    State College, Pennsylvania 16801
    Multiple Myeloma and Plasma Cell Neoplasm
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Geisinger Medical Group - Scenery Park

    Trial Locations
    Geisinger Medical Group - Scenery Park
    Mount Nittany Medical Center
    Metastatic Cancer, Prostate Cancer
    Lenalidomide and Prednisone in Treating Patients With Myelofibrosis
    Mount Nittany Medical Center
    State College, Pennsylvania 16803
    Chronic Myeloproliferative Disorders
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Geisinger Medical Group - Scenery Park

    Trial Locations
    Geisinger Medical Group - Scenery Park
    Mount Nittany Medical Center
    Colorectal Cancer
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    Geisinger Medical Group - Scenery Park
    State College, Pennsylvania 16801
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Mount Nittany Medical Center

    Trial Locations
    Mount Nittany Medical Center
    Geisinger Medical Group
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Mount Nittany Medical Center

    Trial Locations
    Mount Nittany Medical Center
    Geisinger Medical Group
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
    Mount Nittany Medical Center
    State College, Pennsylvania 16803
    Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Ziv-Aflibercept in Treating Patients With Metastatic or Unresectable Kidney Cancer
    Geisinger Medical Group
    State College, Pennsylvania 16801
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Geisinger Medical Group
    State College, Pennsylvania 16801
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
    Geisinger Medical Group - Scenery Park

    Trial Locations
    Geisinger Medical Group - Scenery Park
    Mount Nittany Medical Center
    Esophageal Cancer
    AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors
    Geisinger Medical Group - Scenery Park
    State College, Pennsylvania 16801
    Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Neoplastic Syndrome
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Mount Nittany Medical Center

    Trial Locations
    Mount Nittany Medical Center
    Geisinger Medical Group
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer